Nerve growth factor is preformed in and activates human peripheral blood eosinophils

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 3, 1998, Pages 454-460

  Solomon, Abraham ^a,b   Aloe, Luigi ^c   Pe'Er, Jacob ^a   Pery, Joseph Frucht ^a   Bonini, Stefano ^d   Bonini, Sergio ^e,f   Levi Schaffer, Francesca ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c CNR   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e Institute of Experimental Medicine CNR

^f SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Allergic diseases; Eosinophil peroxidase; IL 6; Nerve growth factor

Indexed keywords

NERVE GROWTH FACTOR;

ADOLESCENT; ADULT; ALLERGIC DISEASE; ARTICLE; CELL ISOLATION; CELL SELECTION; CELL VIABILITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 0031661587     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70135-6     Document Type: Article

References (35)

1. Callissano P, Cattaneo A, Aloe L, Levi-Montalcini R. The nerve growth factor (NGF). In: Hormonal proteins and peptides. Vol XII. New York: Academic Press; 1984. p 1-56.
2. Thoenen H, Edgar D. Neurotrophic factors. Science 1995;229:238.
3. Aloe L, Bracei Laudero L, Bonini S, Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997;52:883-994.
4. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with nerve growth factor. Brain Res 1977;133:358-66.
5. Marshal JS, Stead RH, McSharry C, Nielsen L, Bienenstock J. The role of mast cell degranulation products in mast cell hyperplasia, I: mechanism of action of nerve growth factor. J Immunol 1990;144:1886-92.
6. Matsuda H, Kannan Y, Ushio H, Kiso Y, Kanemoto T, Suzuki H, et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991;174:7-14.
7. Horigome K, Pryor JC, Bullock ED, Johnson EM Jr. Mediator release from mast cells by nerve growth factor: neurotrophin specificity and receptor mediation. J Biol Chem 1993;268:14881-7.
8. Nilsson G, Forsberg-Nilsson K, Xiang L, Hallbook F, Nillson K, Metcalfe DD. Human mast cells express functional TrK A and are a source of NGF. Eur J Immunol 1997;27:2295-301.
9. Tam S-Y, Tsai M, Yamaguchi M, Yano K, Butterfield JH, Galli SJ. Expression of functional TrK A receptor Tyrosine Kinase in the HMC-1 human mast cell line and in human mast cells. Blood 1997;90:1807-20.
10. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 1994;91:3734-9.
11. Bonini S, Lambiase A, Bonini S, Angelucci L, Magrini L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci U S A 1996;93:10955-60.
12. Lambiase A, Bonini ST, Bonini SE, Micera A, Magrini L, Bracci-Laudiero L, et al. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci 1995;36:2127-32.
13. + T-cell clones produce and release nerve growth factor (NGF) and express high affinity NGF receptor. J Allergy Clin Immunol 1997;100:408-14.
14. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1103-89.
15. Levi-Schaffer F, Lacy P, Severs NJ, Newman TM, North J, Gomperts B, et al. Association of granulocyte- macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 1995;85:2576-9.
16. Lacy P, Levi-Schaffer F, Mahmudi-Azer S, Babeitz B, Hajen SC, Velazquez J, et al. Intracellular localization of interleukin-6 in eosinophils from atopic asthmatic and effects of interferon-γ. Blood 1998;91:2508-16.
17. Takafuji S, Bischoff SC, De Weck AL, Dahinden CA. Opposing effects of tumor necrosis factor-α and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionylleucyl-phenylalanine. Eur J Immunol 1992;22:969-74.
18. Hamada A, Watanabe N, Ohtomo H, Matsuda H. Nerve growth factor enhances survival and cytotoxicity of human eosinophils. Br J Hematol 1996;93:299-302.
19. Lambiase A, Bonini ST, Micera A, Rama P, Bonini SE, Aloe L. Expression of NGF receptors on ocular surface in healthy subjects, and during inflammatory diseases. Invest Ophthalmol Vis Sci 1998;39:1272-5.
20. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000 molecular weight protein. Proc Natl Acad Sci U S A 1969;64:787-94.
21. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
22. White SR, Kulp GVP, Spaethe SM, Van Alstyne E, Leff AR. A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media. J Immunol Methods 1991;44:257-63.
23. Bracci-Laudiero L, Aloe L, Levi-Montalcini R. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-12.
24. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol-chloroform extraction. Anal Biochem 1987;162:156.
25. Cartwright M, Mikheev AM, Heinrich G. Expression of neurotrophic genes in human fibroblasts: differential regulation of the brain-derived neurotrophic factor gene. Int J Dev Neurosci 1994;12:685-93.
26. Tomassini M, Tsicopoulos A, Tai PC, Gruart V, Tonnel AB, Prin L, et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophils on immunoglobulin-dependent activation. J Allergy Clin Immunol 1991;88:365-75.
27. Vercelli D, Jabara HH, Arai K, Yokota T, Geha RS. Endogenous IL-6 plays an obligatory role in IL-4 induced human IgE synthesis. Eur J Immunol 1989;18:929.
28. Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC, et al. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1α. Blood 1988;71:1759.
29. Caracciolo D, Clarck SC, Rovera G. Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood 1989;73:666.
30. Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, et al. Effects of T-helper 2-type cytokines interleukin 3 (IL-3), IL-4, IL-5 and IL-6 on the survival of cultured human mast cells. Blood 1995;86:3705-14.
31. Tai PC, Sun L, Spry CJ. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991;85:312-6.
32. Kawamoto K, Okada T, Kannan Y, Ushio H, Matsumoto M, Matsuda H. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the Trk proto-oncogene receptor. Blood 1995;86:4638-44.
33. Greenlund LJS, Korsmeyer SJ, Johnson EM. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron 1995;15:601-49.
34. Torcla M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996;85:345-56.
35. Kannan Y, Usami K, Okada M, Shimizu S, Matsuda H. Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem Biophys Res Commun 1992;186:4638-44.